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forms—visceral (VL) and cutaneous 
leishmaniasis (CL). The illness is caused 
by the protozoan parasites of the genus 
Leishmania and transmitted by the bite of 
hematophagous female infected sandflies. 
It is closely related to poverty and lack of 
resources in many regions of low-income 
countries from Latin America, Asia, and 
Africa.[1,2]
According to the World Health Organi-
zation, CL is a problem in around 100 
countries.[1] CL develops deep disfiguring 
and destructive ulcerated lesions that are 
difficult to treat and prone to secondary 
bacterial and fungal infections.[3] There are 
several limitations of current treatments. 
Pentavalent antimonials are the first-line 
drug of choice and they are based on a reg-
imen of daily injections for a long period.[4] 
Alternatively, amphotericin B has been 
used for unresponsive cases and is admin-
istered by intravenous infusion.[4,5] Miltefo-
sine, an anticancer drug (the only available 
in oral formulation) has also been applied 
for the treatment of CL. However, due to strains resistant to this 
compound, it has not been approved in many countries.
All of these treatments are associated with high toxicity, 
high cost, systemic long-term administration, and drug resist-
ance.[4] These limitations lead not only to severe adverse and 
side effects but also to poor adherence to treatment and con-
sequently relapses in the disease.[5] In addition, patients are 
dependent upon multiple daily injections, which are painful, 
making hospital treatment necessary.[4,5]
Antimicrobial photodynamic therapy (APDT) has emerged 
as a potential alternative treatment for CL with many advan-
tages over the drugs currently used.[6] APDT involves the acti-
vation of a photosensitizer with a light source at a suitable 
 wavelength in the presence of molecular oxygen in order to 
produce reactive oxygen species (ROS).[6] APDT is an attractive 
therapy because of its low cost, broad-spectrum (able to kill bac-
teria, fungi, viruses, and parasites), very low toxicity for mam-
malian cells, and being unlikely to produce resistance due to its 
mechanism of action. In addition, topical administration and 
immediate results may shorten the duration of treatment.[7]
Although there are many benefits of APDT, the widespread 
use of the therapy is limited by the need for specialized, bulky, 
and expensive light sources. Lasers are coherent light sources 
that have been widely used for a long time for small areas, 
mostly in the field of dentistry, or as an antitumor therapy for 
oral or superficial skin lesions.[8] However, their high-cost, and 
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1. Introduction
Leishmaniasis is an important neglected tropical disease that 
affects over 200 countries across the world.[1] It comes in two 
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(in many cases) high level of technical support required, turns 
them into an undesirable tool to be used in mainstream medi-
cine.[9,10] Furthermore, they emit narrow beams which present a 
hazard to the eye and are ill-adapted to uniform illumination of 
an area to be treated.
To overcome these issues, incoherent inorganic light-emit-
ting diodes (LEDs) have been implemented as alternative light 
sources with broader emission spectra, able to deliver light 
over a large area, being suitable for the treatment of larger skin 
lesions.[11,12] Despite the high efficiency of LEDs, they intrinsi-
cally are point sources so manufacturing them might still be a 
challenge in terms of emission uniformity, besides light being 
unable to be delivered evenly onto curved surfaces.[13] At pre-
sent, inorganic LEDs for APDT are bulky machines found in a 
limited number of hospitals and clinics.
Advances in organic light-emitting materials now provide 
an alternative route to light sources for medical applications. 
Organic light-emitting diodes (OLEDs) have many attractive 
features for medical applications[14–17] such as being light-
weight, thin light sources that are flexible and inexpensive. 
These properties make them ideal for wearable light sources 
for ambulatory APDT.[18] They have recently been reported as 
novel light sources for bacteria inactivation.[14] A particular 
advantage of OLEDs is that they are intrinsically area light 
sources, and so well matched to treating topical infections and 
lesions, which require uniform illumination over their surface 
area. OLEDs have been shown to be very effective for treating 
skin cancer in human patients.[18] Although OLEDs have been 
described as promising light sources for antitumor therapy, so 
far their antimicrobial efficiency has only been reported for 
treating bacterial infections.[14] Thus, it is worth investigating 
their potential as light sources for CL.
In this paper, we evaluated the effectiveness of OLEDs com-
bined with three different phenothiazine dyes: methylene blue 
(MB), new methylene blue (NMB), and 1,9-dimethyl-methylene 
blue (DMMB), against two species of Leishmania promastig-
otes (Leishmania major and Leishmania amazonensis), which 
cause CL.[19] Phenothiazine-based photosensitizers have been 
chosen not only due to their ability to generate ROS but also 
because they are cost-effective and so could be widely used.[19,20] 
Our study started by designing and making suitable OLEDs, 
and then applying them to in vitro assays in 96-well plates. 
Our results demonstrate that OLEDs are effective for all three 
photosensitizers, suggesting the great potential of OLEDs to be 
used as light sources for ambulatory APDT to treat cutaneous 
leishmaniasis.
2. Experimental Section
2.1. OLED Fabrication and Characterization
OLEDs were fabricated by thermal evaporation at a base pres-
sure of 3 × 10−7 mbar (EvoVac, Angstrom Engineering Inc.). 
Materials used in the OLED fabrication were as follows: 
300 nm aluminum as anode, 50 nm 2,2′,7,7′-tetrakis(N,N′-di-p-
methylphenylamino)-9,9′- spirobifluorene (Spiro-TTB) doped 
with 2,2′-(perfluoronaphthalene-2,6-diylidene)dimalononitrile 
(F6-TCNNQ) (4 wt%) as hole-transport layer, 10  nm N,N′-
di(naphtalene-1-yl)-N,N′-diphenylbenzidine (NPB) as electron- 
blocking layer, 40  nm NPB doped with [Ir(MDQ)2(acac)] 
(10 wt%) as emission layer, 10 nm bis-(2-methyl-8-chinolinolato)-
(4-phenyl-phenolato)-aluminium(III) (BAlq) as hole-blocking 
layer, 70  nm 4,7-diphenyl-1,10-phenanthroline (BPhen) doped 
with cesium as electron-transport layer, 20  nm silver as semi-
transparent cathode, and 80  nm NPB as capping layer. The 
OLEDs were encapsulated in the glove box under a nitrogen 
atmosphere with glass lids and UV-curable epoxy glue (Norland 
NOA68).
The electrical characteristics of OLEDs were measured with 
a source-measure unit (Keithley 2400, Keithley). The EL spectra 
of the OLEDs were obtained using a spectrograph (MS125, 
Oriel) coupled to a charge-coupled device (CCD) camera 
(DV420-BU, Andor). The irradiance of OLEDs was measured 
with an optometer (P9710, Gigahertz Optik). The emission uni-
formity of OLEDs was measured on the center of each well in 
the 96-well plate with a fiber-coupled CCD camera. Then, the 
irradiances of each position were calculated according to the 
relative light intensity measured by a CCD camera.
2.2. Parasites
L. amazonensis (MHOM/BR/73/M2269) and L. major (MHOM/
IL/80 Fredlin) promastigotes were grown at 28  °C in M199 
medium (Sigma-Aldrich) supplemented with 10% heat-inac-
tivated fetal bovine serum (FBS; Gibco Invitrogen Corpora-
tion), HEPES (40 × 10−3 m) pH 7.4 (Sigma-Aldrich), hemin 
(2.5  mg mL−1) (Sigma-Aldrich), and adenosine (10 × 10−3 m) 
(Sigma-Aldrich).[21]
2.3. Phenothiazine-Based APDT of Leishmania spp
The activity of APDT against both Leishmania species was car-
ried out by the addition of serial dilutions of MB (100 µL, 0 × 
10−6 to 100 × 10−6 m) (Sigma-Aldrich), NMB (0 × 10−6 to 10 × 
10−6 m) (Sigma-Aldrich), or DMMB (0 × 10−9 to 3000 × 10−9 m) 
(Sigma-Aldrich) into a 96-well plate. Parasites were then seeded 
at 1 × 106 per well in a final volume of 200 µL and incubated 
with the corresponding photosensitizer (MB, NMB, or DMMB) 
for 10 min to allow the photosensitizer uptake by the parasites 
before irradiation. Afterwards, APDT was performed using two 
different light sources (LED or OLED) in separated plates. Light 
parameters were set as described in Table 1.
Parasite toxicity of the three photosensitizers with no light 
was assessed by their incubation at increasing concentrations 
of MB (0 × 10−6 to 100 × 10−6 m), NMB (0 × 10−6 to 10 × 10−6 m), 
or DMMB (0 × 10−9 to 3000 × 10−9 m), in the dark for 2 h. 
Table 1. Light source parameters for APDT.
LED OLED
Radiant exposure [J cm−2] 50 50
Intensity [mW cm−2] 20 6.5
Time [min] 41′ 39″ 128′ 12″
λ [nm] 660 ± 12.5 671 ± 140
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Control groups receiving only light (LED or OLED) were also 
evaluated using the same parameters described in Table 1.
Then, parasite viability assay was assessed at the end of each 
experiment by the addition of resazurin (Alamar blue, Sigma-
Aldrich), a nonfluorescent compound that undergoes a cellular 
metabolic reduction becoming highly fluorescent in the pres-
ence of living cells. Briefly, a stock solution (10 µL,1.1 mg mL−1), 
dissolved in PBS, was added in each well and incubated for 5 h 
at 28  °C.[22] Afterwards, the fluorescence intensity was deter-
mined by using a plate reader (Gen5 Reader, BioTek) at λexc = 
530 nm and λem = 590 nm. Results were then normalized and 
expressed as a percentage of live parasites.
2.4. OLED-APDT Light Dose Study of L. amazonensis
OLED-APDT efficiency at various radiant exposures was eval-
uated against L. amazonensis in the presence of increasing 
concentrations of DMMB, as this was the most potent photo-
sensitizer. Parasites were seeded in 96-well plates as described 
previously and exposed to light of 6.5 mW cm−2 at different 
radiant exposures as shown in Table 2.
We also explored reduced OLED intensity of 1.5 mW cm−2 
and compared with LED at 8 J cm−2 (20 mW cm−2). To further 
investigate OLED-APDT at lower intensity, it was reduced to 
0.7 mW cm−2 at the lowest radiant exposure delivering 2 J cm−2. 
Experiments were performed as described in Tables 3 and  4. 
Then, parasite viability assay was assessed at the end of each 
experiment as mentioned in “Phenothiazine-based APDT of 
Leishmania spp.” section.
2.5. Statistical Analysis
Data were obtained in triplicates and were analyzed by two-way 
analysis of variance (ANOVA). Differences were considered sta-
tistically significant when p < 0.05.
3. APDT Light Sources for Treating Cutaneous 
Leishmaniasis
3.1. Requirements of Light Sources for APDT
The light source is one of the three key components in APDT, and 
advances in light-emitting materials provide new opportunities 
that we explore in this paper. The light source is so important 
because it excites the photosensitizers to the excited state, leading 
to the generation of ROS. The first requirement for the light 
source is therefore that it can efficiently excite the photosensitizer. 
This means that it must emit light at a wavelength (or range of 
wavelengths) that is strongly absorbed by the photosensitizer. A 
good match of the emission spectrum of the light source to the 
absorption of the photosensitizer can reduce the light output 
needed to achieve a given level of ROS production. In addition to 
having a suitable emission spectrum, the light sources also need 
to be efficient. Highly efficient light sources can lower the power 
consumption so that the light sources are able to reach high 
output intensity (radiant exitance) with low heat generation. For 
ambulatory APDT where the light sources are placed on human 
skin, reducing heat generation is particularly important as other-
wise the light source could (in the worst case) burn the patient, or 
be very uncomfortable. The third requirement of the light source 
is that it should have high output intensity, in order to generate 
ROS fast enough for effective APDT. For large area treatment, 
the light source needs to have high uniformity in order to deliver 
similar light doses over an area. Last, but not least, APDT is devel-
oping toward ambulatory treatment, in which the patient can 
move around. So, the light sources will need to be lightweight and 
preferably flexible to adapt to the curvature of the human body.
3.2. Development of OLEDs for APDT
Here we developed large area OLEDs, specifically for APDT 
on 96-well plates. A highly efficient red phosphorescent mate-
rial bis(2-methyldibenzo [f,h]quinoxaline)(acetylacetonate) 
iridium(III) [Ir(MDQ)2(acac)] was selected as the emitter for the 
OLEDs. In order to have an effective excitation of the photosen-
sitizers, the OLEDs were designed in a top emitting geometry 
with a thick Al bottom electrode and a semitransparent silver top 
electrode (Figure 1a). The metal electrodes also act as reflecting 
mirrors so that the OLED is a planar microcavity. Therefore, by 
simply changing the layer thicknesses between the two metal 
contacts, the emission peak of OLEDs can be tuned. The elec-
trical and optical performance of the OLEDs are shown in 
Figure  1b. A low turn-on voltage was achieved by using doped 
transport layers. Low driving voltage due to the doped trans-
port layers is important because it reduces joule-heating and so 
enables higher light outputs to be reached. Another advantage 
of using doped layers is that the emission peak can be tuned 
by varying the transport layer thickness without changing the 
conductivity of the OLEDs. As a result, our large area OLEDs 
achieved a high intensity of 11 mW cm−2 at a current density 
of 45 mA cm−2 and applied voltage 3.96 V. The OLED emission 
Table 2. OLED-APDT exposure times to give different radiant exposures 
at intensity 6.5 mW cm−2.







Table 3. LED and OLED-APDT parameters at radiant exposure 





Intensity [mW cm−2] 20 6.5 1.5
Time 6′ 39″ 20′ 30″ 88′ 52″
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spectrum was tuned to peak at 671  nm, which matches the 
absorption bands of MB, DMMB, and NMB (Figure 2).
As explained above, uniformity of illumination is desirable, 
but it can be hard to achieve in large area OLEDs because of the 
high sheet resistance of the thin metal layer. The voltage-drop in 
the contact can induce a difference in the device driving voltage 
across the emitting area and affect the uniformity of emission. 
Here, we introduced a grid of silver contacts 2  µm thick to 
spread current around the edge of the emitting region of the top 
contact. We also made the bottom contact of aluminum 300 nm 
thick to minimize resistive losses. These measures led to light 
output being uniform within ±13% of its mean value at an irra-
diance of 6.5 mW cm−2 over the 31.9 mm by 40.9 mm emitting 
area (Figure S1, Supporting Information). This was considered a 
satisfactory level of uniformity for the APDT experiments.
OLEDs were prepared for APDT experiments on 96-well 
plates. The devices consisted of four OLED pixels of the design 
described above fabricated together on a single glass substrate. 
The size of each OLED pixel was 32 mm by 41 mm and it could 
fully cover 12 wells (Figure 1b) with uniform illumination. Four 
switches that can individually control each pixel were imple-
mented so that light and dark conditions can be applied to dif-
ferent regions of the same well plate, as desired. This OLED 
geometry in combination with the 96-well plates enables many 
APDT experiments to be done at once, and the uniformity within 
a single well is better than that for LED illumination, as OLEDs 
generate light over an area rather than being point light sources.
3.3. Development of Inorganic LEDs for APDT
For comparison with the OLEDs, a light source consisting of 
inorganic LEDs was also made. It consisted of 12 LEDs (660 nm 
OSLON SSL, OSRAM) arranged in a 3 × 4 grid. LEDs emitting 
at a wavelength 660 nm were selected to match the absorption 
of the photosensitizers used in our experiments (Figure  2). 
The experimental setup also accommodates 96-well plates 
(Figure S2, Supporting Information) and illuminates simulta-
neously 12 wells from underneath, with distance 4  mm from 
the bottom of the well. It gives good beam uniformity around 
±5%  within one well. A constant current power supply for 
driving the LEDs was built with three user-selectable currents, 
which produced intensity range 12.5, 25, and 50 mW cm−2.
4. Results
APDT is well known for giving results quickly due to the high 
amounts of ROS produced that are able to kill neighboring 
microbial cells. In order to measure the potential of three dif-
ferent phenothiazine dyes activated by either LED or OLED, 
the metabolic activity of parasites was measured directly after 
therapy. Light sources were set to deliver 50 J cm−2: ≈42 min 
at 20 mW cm−2 for the LED and 128 min at 6.5 mW cm−2 for 
the OLED (see Table 1). The results are plotted in Figure 3 and 
show that even at the lowest concentration, APDT produced a 
significant cellular inactivation of both Leishmania species. This 
inactivation was achieved by both light sources. In contrast, no 
inactivation was observed in most of the control experiments of 
i) light without photosensitizer, and ii) photosensitizer without 
light. However, for DMMB at 3000 × 10−9 m the photosensitizer 
without light did lead to some inactivation – 43.5 ± 2.8%  for 
L. amazonensis and 27.3 ± 6.1%  for L. major (Figure S3, Sup-
porting Information).
Our results show that both OLEDs and LEDs are effec-
tive light sources for APDT, and work well with a range of 
Table 4. OLED-APDT parameters at radiant exposure of 2 J cm−2.
OLED
Radiant exposure [J cm−2] 2 2 2
Intensity [mW cm−2] 6.5 1.5 0.7
Time 5′ 7″ 22′ 14″ 47′ 36″
Figure 1. a) OLED structure designed for APDT and supporting grid structure for uniformity enhancement. b) Voltage–current density–irradiance 
(V–J–Irradiance) of OLED designed for APDT. The inset shows a photograph of four OLED pixels illuminating a 96-well plate.
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photosensitizers and/or Leishmania species. In some cases, 
the inactivation was larger for OLED-APDT (Figure 4). For 
example, for MB at 6.25 × 10−6 m, LED-APDT killed an average 
of 46.6 ±  1.6% and 53.3 ±  5.4% for L. major and L. amazon-
ensis, respectively, whereas OLED-APDT, caused an inactiva-
tion of 51.2 ±  1.4% and 86.9 ±  0.6% for the same species. It 
is worth noticing that in terms of LED-APDT, both species 
showed a significant dependence on MB concentration. A sim-
ilar dependence was observed for OLEDs with L. major. How-
ever, this trend was no longer observed when L. amazonensis 
was exposed to OLEDs, and a similar killing rate was observed 
across the concentration range from 6.25 × 10−6 to 100 × 10−6 m 
(Figures 3a,d and 4a,d).
The results for the photosensitizer NMB are shown in 
Figure 3b,e, and the same pattern is observed. Here it is very 
clear that OLEDs have a greater effect than LEDs on both Leish-
mania species, especially at lower concentrations (Figure 4b,e). 
An average of 90.5 ±  1.5% and 59.7 ±  3.8% of L. amazonensis 
and L. major were killed by OLED-APDT at 0.6 × 10−6 m, which 
is much more than for LED-APDT, which killed 58 ±  1.5% of 
L. amazonensis and 13 ± 3.1% of L. major.
When DMMB was used as the photosensitizer, LED-APDT 
and OLED-APDT provided similar results for the lowest and the 
highest concentrations (Figures 3c,f and 4c,f). An average of 37.3 
± 12.4% and 81.8 ± 4.2% of L. major were inactivated by the LED 
source at 187 × 10−9 and 3000 × 10−9 m, respectively. The killing 
rate of L. major achieved by the OLED was 42 ± 4.5% at 187 × 
10−9 m and 82.5 ± 0.4% at 3000 × 10−9 m. For L. amazonensis the 
OLED killed 86.4 ±  0.9% and 92.9% ± 0.4% at 187 × 10−9 and 
3000 × 10−9 m, respectively, whereas 70.4 ± 4.5% and 94 ± 0.4% 
were killed at the same concentrations by LEDs.
Indeed, L. amazonensis appears to be more susceptible to 
APDT than L. major under all conditions, i.e., regardless of the 
photosensitizer or light source. Overall, DMMB turned out to 
be the most potent photosensitizer since it is able to promote 
an effective killing rate at low (nanomolar) concentrations.
As L. amazonensis was the most susceptible cell line to 
APDT, parasites were exposed to increasing concentrations 
of DMMB (the best photosensitizer), under a wide range of 
radiant exposures (from 2 to 50 J cm−2), in order to further 
investigate the effectiveness of OLED APDT. Figure 5a shows 
the photosensitizer concentration–response curve fit at radiant 
exposures from 2 to 50 J cm−2, obtained by using 6.5 mW cm−2 
for times from 5 to 128 min (Table  2). The results show that 
at 8 J cm−2, the rate of killing is not significantly different from 
that for 50 J cm−2. The parasites are likely being inactivated in 
the first 20 min: 85.4 ±  4.5% for 187 × 10−9 m photosensitizer 
and 98.4 ± 0.4% for 3000 × 10−9 m, photosensitizer.
The intensity supplied by the OLED was then reduced in 
order to deliver 8 J cm−2 at 1.5 mW cm−2 over 90 min. The 
LED intensity was kept at 20 mW cm−2, delivering the same 
radiant exposure in 6 min, as described in Table 3. As shown 
in Figure  5b, APDT was more effective for the OLED at the 
lowest concentration (187 × 10−9 m), promoting significant para-
site reduction when treating L. amazonensis cells with DMMB. 
The OLED achieved 86.5 ± 4.9% inactivation for 6.5 mW cm−2 
illumination, and 72.4 ± 6.5% inactivation for 1.5 mW cm−2 illu-
mination, whereas the LED achieved 61.4 ± 3.5% inactivation at 
20 mW cm−2. A similar trend of OLEDs operating at low inten-
sities being more effective than the LED source is also seen at 
the other concentrations.
Moreover, according to Figure 5a, even at the lowest radiant 
exposure (2 J cm−2), parasite load was reduced significantly, for 
all the DMMB concentrations. Data show that 64.7 ± 3.9% and 
94.1 ±  0.4% of cells were killed when treated with DMMB at 
the lowest and highest concentration. Therefore, we used these 
data as the basis for the next step in optimizing OLED-APDT 
and lowered OLED intensity even further to 0.7 mW cm−2. The 
OLED was set to deliver 2 J cm−2 over ≈50 min to compare 
OLED-APDT at different intensities, as shown in Table 3. The 
results are shown in Figure 5c, and the death rate is unchanged 
despite the reduced intensity. For example, 96.5 ± 0.9%  of 
cells were inactivated at a photosensitizer concentration of 
1500 × 10−9 m, suggesting the pronounced impact of OLED as 
a potential tool to be used for antileishmanial therapy.
5. Discussion
In this work, we have successfully developed OLED light 
sources for APDT of cutaneous leishmaniasis. We then evalu-
ated their effectiveness in vitro using three phenothiazine-
based dyes as photosensitizers. We find that both OLEDs and 
LEDs are able to inactivate both L. major and L. amazonensis 
regardless of the photosensitizer concentration.
MB is a well-known dye that has been widely employed as 
a photosensitizer due to its absorption lying in the red region 
Figure 2. a) Electroluminescence spectra of OLED and LED. b) Absorp-
tion spectra of methylene blue (MB), new methylene blue (NMB), and 
1,9-dimethyl-methylene blue (DMMB) in deionized water.
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of the spectrum, with two absorption peaks at 609 and 660 nm 
(Figure 2). MB is able to generate high amounts of ROS either 
by Type I reaction, such as O2−, OH−, and H2O2, or by Type II 
reaction, achieving a singlet oxygen quantum yield of nearly 
0.44.[20] In terms of application, it has been demonstrated to pro-
mote promising results against a wide range of microbial spe-
cies, mostly bacteria, and fungi, including resistant strains.[23,24] 
As an antileishmanial agent, in vitro and in vivo studies show 
its potential, reporting not only its ability to reduce the para-
site burden in preclinical trials but also to treat human patients 
with impressive cosmetic results.[25–27]
However, the vast majority of APDT light sources are LED-
based and although they allow illumination over a large area, 
occasionally light is unable to be delivered uniformly as a result 
of shadow formation. We have shown that OLEDs provide a 
new light source for PDT of Leishmania species that is at least 
Figure 3. L. major and L. amazonensis promastigotes treated with LED and OLED-APDT at 50 J cm−2 in the presence of increasing concentrations of 
a,d) MB, b,e) NMB, and c,f) DMMB. Values shown represent the mean ± SD.
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as effective as LEDs and offers further advantages. OLEDs are 
more compact, can be flexible, and give uniform light emission 
over an area. Although the lower OLED irradiance resulted in a 
longer irradiation time to achieve the same light doses used for 
LED-APDT, this is not a problem as the OLEDs could potentially 
be worn as a light source and longer exposure time gives more 
time for oxygen to diffuse to the region to be treated. Another 
feature is that OLEDs have a broader emission spectrum than 
LEDs, which gives good overlap with the absorption of all the 
photosensitizers (Figure 2). The wider emission spectrum also 
means that OLEDs could excite both monomers and dimers of 
MB simultaneously. This would promote both Type I and Type 
II reactions, and so may enhance parasite inactivation.[28,29]
Phenothiazinium derivatives are cationic molecules that are 
able to interact more efficiently with the negatively charged par-
asitic membranes, rather than anionic or neutral compounds, 
turning them into attractive agents for APDT.[30] A consider-
able number of MB analogues, such as NMB and DMMB, 
have arisen as new alternatives to MB because of their higher 
lipophilicity, as well as their ability to generate 35% and 21% 
more singlet oxygen than MB.[19,20] As a result, NMB has been 
shown to promote antimicrobial effects against different micro-
organisms such as Streptococcus mutans and Candida albicans 
biofilms, including animal models.[31,32]
In our work, we have demonstrated the great potential of 
NMB under red light illumination, in which we have been able 
to efficiently inactivate the parasites at concentrations nearly 
100 times lower than those of MB. This significant effect was 
also even clearer for OLED-APDT. As the NMB maximum 
absorption peaks is at 590  nm, with another peak at 630  nm, 
NMB only partially absorbs LED irradiation because the LED 
emission consists of a narrow peak at 660 nm. In contrast the 
Figure 4. Comparison between OLED and LED-APDT. L. major and L. amazonensis promastigotes treated at 50 J cm−2 in the presence of increasing 
concentrations of a,d) MB, b,e) NMB, and c,f) DMMB. Values shown represent the mean ± SD. Statistically significant differences observed between 
OLED and LED are marked with *p < 0.05.
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wider emission spectrum of the OLED can excite the NMB, 
which provided an increased death rate.
DMMB is a dimethylated derivative of MB that has been 
shown to be more resistant to photobleaching.[33] In addition, it 
is more effective as can be seen from the excellent improvement 
in the killing rate of Leishmania species at low (nanomolar) 
concentrations (Figures  3e,f and  4e,f). As mentioned above, 
the improvement is due to its increased  lipophilicity (positive 
log P value), in contrast to the hydrophilic nature of MB (log 
P  <  0).[33] Thus, DMMB as a cationic lipophilic compound is 
most likely to target and accumulate in the Leishmania mito-
chondrion.[33] Since Leishmania parasites possess only one large 
ramified mitochondrion, we suggest that APDT disrupts the 
membrane potential resulting in a pronounced cellular killing.
There have been very few reports to date regarding the 
phototoxic effects of DMMB, and most of them are related 
to its use as an antibacterial agent under LED-based light 
sources.[34,35] As far as we know, our work is the first report 
of the use of DMMB against Leishmania species. We find that 
both light sources significantly decrease the parasite's survival 
under DMMB application in a photosensitizer concentration-
dependent manner.
To further investigate the potential of OLEDs, we explored 
lower intensities at the same radiant exposure (2 J cm−2), 
resulting in effective killing even at low photosensitizer con-
centrations. We found very effective killing by 20 min of illu-
mination at 1.5 mW cm−2. Illumination for longer times using 
0.7 mW cm−2 was slightly less effective (Figure 5c). This may be 
because 2 J cm−2 at mW cm−2 is insufficient to fully overcome 
the antioxidant capacity of L. amazonensis. We also note that 
20 min of illumination delivering 8 J cm−2 at 6.5 mW cm−2 
gave very effective inactivation compared with other intensi-
ties, especially at low DMMB concentrations (Figure  5a,b). 
Taken together, these findings suggest that the use of an 
appropriate light dose in combination with a suitable intensity 
is needed to achieve the largest antileishmanial effect.
The effectiveness of APDT depends on many variables 
including the parameters of the illumination, the properties of 
the photosensitizer, and how it interacts with the cells, the light 
source, and oxygen. Leishmania spp. contain superoxide dis-
mutase, peroxidases, and a series of thiol-containing proteins that 
act as antioxidants for ROS generated by Type I reactions.[36,37] 
In addition, there are differences in the biology of Leishmania 
species, including in the redox system.[38] Our observation that 
L. amazonensis is killed more effectively than L. major can be 
explained by the latter containing peroxidases capable of scav-
enging high levels of H2O2, making it more tolerant of ROS.[39,40] 
As a result, a Type II reaction is preferred to target L. major since 
there are not endogenous antioxidant defenses for singlet oxygen. 
This may also explain why DMMB was particularly effective. It 
has a high singlet oxygen quantum yield (by Type II reaction), so 
more oxidative stress was generated in the cells in the short-term, 
achieving faster killing at lower concentrations.[33]
In conclusion, we have demonstrated that OLEDs are very 
promising light sources for APDT. Importantly, we have shown 
that they are very effective for APDT to kill two different strains 
of Leishmania parasites. Additionally, a recent study by Pereira 
et  al. showed no cytotoxicity of the three photosensitizers on 
mammalian cells.[41] We also found that this could be achieved 
at relatively low intensities and very low photosensitizer con-
centration. Our in vitro results suggest that OLED-APDT is a 
promising direction for potential ambulatory care of patients 
who suffer from cutaneous leishmaniasis that should be fol-
lowed up by in vivo studies.
Figure 5. L. amazonensis promastigotes treated with LED and OLED-
APDT in the presence of increasing concentrations of DMMB. a) OLED 
at different radiant exposures and intensity of 6.5 mW cm−2. b) OLED at 
8 J cm−2 and intensities of 6.5 and 1.5 mW cm−2. LED-APDT was per-
formed at the same radiant exposure and intensity of 20 mW cm−2; 
c) OLED-APDT at 2 J cm−2 and different intensities (0.7, 1.5 and 
6.5 mW cm−2). Values shown represent the mean ± SD (* denotes statisti-
cally significant differences between LED and OLED-PDT).
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